São Paulo, Brazil. May 17 – EDAN Instruments, Inc. (300206. SZ) got back to Hospitalar 2022, currently on display at the São Paulo Expo from May 17 to 20. As one of the most influential platforms in the healthcare industry for the Latin America, Hospitalar attracted over 1,000 exhibitors and 90,000 industry visitors this year.
“We’re excited to be back to Brazil after an absence of three years,” said Eric Li, EDAN’s senior regional manager. “We have many years of experience exhibiting at Hospitalar, and we seized it as a great opportunity to bond with the local market. We will continue to put our focus on the voice of end-users, introducing our newest products and customer-centric services to the world.”
Two ready-to-launch products, 3rd Generation patient monitor, iX Series, and the integrated portable version biofeedback and stimulation system, PA4 Pro, made their first debut for the Latin American audiences on Hospitalar 2022. Visitors could directly experience their efficient workflow and be enticed by their landmark functions in relative fields.
EDAN’s flagship 12-channel ECG, SE-1202, and the 5-part auto hematology analyzer H60S were also arriving on stage in Latin America for the first time. SE-1202 adopts a glass panel design with a large touch screen, giving practitioners a better view of information and making the device easy to disinfect and clean. H60S is equipped with an integrated, intuitive operating system to satisfy the demand for the heavy workload. Both are unambiguously designed in the interest of end-users.
“Optimizing the operation experience and adding clinical values are EDAN’s constant goals,” Eric added. “We believe our products can impress our audiences by their performance and value for applications, especially in such a face-to-face format.”
During the 4-day journey, EDAN is expected to meet a significant amount of healthcare and trade professionals from throughout Latin America and beyond, with implications for millions of people’s health.
For more information, please visit www.edan.com.